Biocryst Pharmaceuticals reported $2B in Market Capitalization this December of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Biocryst Pharmaceuticals BCRX:US USD 2.34B 376M
Chugai Pharma 4519:JP JPY 6.09T 261.93B
Daiichi Sankyo 4568:JP JPY 7.87T 1.18T
Dbv Technologies DBVT:US USD 329M 87M
Enanta Pharmaceuticals ENTA:US USD 1.08B 96M
Gilead Sciences GILD:US USD 77.36B 170M
Glaxosmithkline GSK:US GBP 59.27B 50.02B
GlaxoSmithKline GSK:LN GBP 53.11B 36.65B
Intra Cellular Therapies ITCI:US USD 4.41B 977M
Karyopharm Therapeutics KPTI:US USD 442M 82M
Mirati Therapeutics MRTX:US USD 3.88B 156M
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Novavax NVAX:US USD 1.42B 2.6B
Ptc Therapeutics PTCT:US USD 3.61B 742M
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Roche Holding ROG:VX CHF 263.11B 68.64B
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
YTE INCY:US USD 14.82B 2.01B